BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 18569371)

  • 1. A sandwich ELISA for phosphoglycerate kinase.
    Zhao W; Pao S; Malik F; Soh J; Fernandez S; Chirico WJ
    J Immunoassay Immunochem; 2008; 29(3):220-33. PubMed ID: 18569371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphoglycerate kinase acts in tumour angiogenesis as a disulphide reductase.
    Lay AJ; Jiang XM; Kisker O; Flynn E; Underwood A; Condron R; Hogg PJ
    Nature; 2000 Dec; 408(6814):869-73. PubMed ID: 11130727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression and elevated serum levels of phosphoglycerate kinase 1 in pancreatic ductal adenocarcinoma.
    Hwang TL; Liang Y; Chien KY; Yu JS
    Proteomics; 2006 Apr; 6(7):2259-72. PubMed ID: 16493704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphoglycerate kinase 1 (PGK1) in cancer: A promising target for diagnosis and therapy.
    Fu Q; Yu Z
    Life Sci; 2020 Sep; 256():117863. PubMed ID: 32479953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human kallikrein 14: a new potential biomarker for ovarian and breast cancer.
    Borgoño CA; Grass L; Soosaipillai A; Yousef GM; Petraki CD; Howarth DH; Fracchioli S; Katsaros D; Diamandis EP
    Cancer Res; 2003 Dec; 63(24):9032-41. PubMed ID: 14695222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perturbation of phosphoglycerate kinase 1 (PGK1) only marginally affects glycolysis in cancer cells.
    Jin C; Zhu X; Wu H; Wang Y; Hu X
    J Biol Chem; 2020 May; 295(19):6425-6446. PubMed ID: 32217690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A highly sensitive immuno-polymerase chain reaction assay for Clostridium botulinum neurotoxin type A.
    Chao HY; Wang YC; Tang SS; Liu HW
    Toxicon; 2004 Jan; 43(1):27-34. PubMed ID: 15037026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PGK1 as an immune target in Kawasaki disease.
    Cui J; Zhou Y; Hu H; Zhao L; Du Z; Du H
    Clin Exp Immunol; 2018 Dec; 194(3):371-379. PubMed ID: 30113070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative study of SPR and ELISA methods based on analysis of CD166/ALCAM levels in cancer and control human sera.
    Vaisocherová H; Faca VM; Taylor AD; Hanash S; Jiang S
    Biosens Bioelectron; 2009 Mar; 24(7):2143-8. PubMed ID: 19157844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular characterization of the 3-phosphoglycerate kinase gene (PGK1) from the methylotrophic yeast Pichia pastoris.
    de Almeida JR; de Moraes LM; Torres FA
    Yeast; 2005 Jul; 22(9):725-37. PubMed ID: 16034819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roles and mechanisms of phosphoglycerate kinase 1 in cancer.
    Chen Y; Cen L; Guo R; Huang S; Chen D
    Bull Cancer; 2022 Dec; 109(12):1298-1307. PubMed ID: 36096942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Developing a double-antigen sandwich ELISA for effective detection of human hepatitis B core antibody.
    Deng LJ; Xu Y; Huang J
    Comp Immunol Microbiol Infect Dis; 2008 Nov; 31(6):515-26. PubMed ID: 18242704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Orotate phosphoribosyltransferase levels measured by a newly established enzyme-linked immunosorbent assay in gastric carcinoma.
    Sakurai Y; Sakamoto K; Sugimoto Y; Yoshida I; Masui T; Tonomura S; Inaba K; Shoji M; Nakamura Y; Uyama I; Komori Y; Ochiai M; Matsuura S; Tanaka H; Oka T; Fukushima M
    Cancer Sci; 2006 Jun; 97(6):492-8. PubMed ID: 16734727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PGK1 : An Essential Player in Modulating Tumor Metabolism.
    Duncan L; Shay C; Teng Y
    Methods Mol Biol; 2022; 2343():57-70. PubMed ID: 34473315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of an immunoassay for serum caveolin-1: a novel biomarker for prostate cancer.
    Tahir SA; Ren C; Timme TL; Gdor Y; Hoogeveen R; Morrisett JD; Frolov A; Ayala G; Wheeler TM; Thompson TC
    Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3653-9. PubMed ID: 14506154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of human phosphoglycerate kinase 1 (PGK1) induces a multidrug resistance phenotype.
    Duan Z; Lamendola DE; Yusuf RZ; Penson RT; Preffer FI; Seiden MV
    Anticancer Res; 2002; 22(4):1933-41. PubMed ID: 12174867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The basic functions of phosphoglycerate kinase 1 and its roles in cancer and other diseases.
    Liu H; Wang X; Shen P; Ni Y; Han X
    Eur J Pharmacol; 2022 Apr; 920():174835. PubMed ID: 35183535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphoglycerate kinase (PGK) 1 succinylation modulates epileptic seizures and the blood-brain barrier.
    Luo Y; Yang J; Zhang L; Tai Z; Huang H; Xu Z; Zhang H
    Exp Anim; 2023 Nov; 72(4):475-489. PubMed ID: 37258131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new model ELISA, based on two monoclonal antibodies, for quantification of fatty acid synthase.
    Wang YY; Kuhajda FP; Cheng P; Chee WY; Li T; Helzlsouer KJ; Sokoll LJ; Chan DW
    J Immunoassay Immunochem; 2002; 23(3):279-92. PubMed ID: 12227415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two proliferation-related proteins, TYMS and PGK1, could be new cytotoxic T lymphocyte-directed tumor-associated antigens of HLA-A2+ colon cancer.
    Shichijo S; Azuma K; Komatsu N; Ito M; Maeda Y; Ishihara Y; Itoh K
    Clin Cancer Res; 2004 Sep; 10(17):5828-36. PubMed ID: 15355913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.